Skip to search formSkip to main contentSkip to account menu

disodium ascorbyl campestanyl phosphate

Known as: disodium ascorbyl phytostanol phosphate 
National Institutes of Health

Related topics

Related topics

1 relation

Narrower (1)

FM-VP4 compound

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
The effect of two novel cholesterol-lowering agents, disodium ascorbyl phytostanol phosphate (DAPP) and nanostructured aluminosilicate (NSAS) on the expression and activity of P-glycoprotein within…
BackgroundMany drugs are substrates for P-glycoprotein (P-gp) and interactions involving P-gp may be relevant to clinical… 
2012
2012
Evaluation of the effect of plant sterols on the intestinal processing of cholesterol using an in vitro lipolysis model.
Review
2008
Review
2008
Current and Future Pharmacologic Options for the Management of Patients Unable to Achieve Low-Density Lipoprotein-Cholesterol Goals with Statins
Low-density lipoprotein-cholesterol (LDL-C) lowering is the mainstay of the current treatment guidelines in the management of… 
2008
2008
Disodium ascorbyl phytostanol phosphate. A new cholesterol-lowering drug?
  • K. Bergmann
  • European Journal of Clinical Pharmacology
  • 2008
  • Corpus ID: 30317950
The Adult Treatment Panel III (ATP III) Guidelines [1] have revised the treatment goals for the reduction of lowdensity… 
2006
2006
Effects of different phytosterol analogs on colonic mucosal cell proliferation in hamsters.
2005
2005
Effects of a water-soluble phytostanol ester on plasma cholesterol levels and red blood cell fragility in hamsters
The aim of this study was to assess the efficacy of a novel water-soluble phytostanol anolog, disodium ascorbyl phytostanyl… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License